|
Volumn 472, Issue , 2000, Pages 187-198
|
Post-translational modifications of eukaryotic initiation factor-5A (eIF-5A) as a new target for anti-cancer therapy
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
CYTARABINE;
DEFEROXAMINE;
EPIDERMAL GROWTH FACTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
HYPUSINE;
INITIATION FACTOR 5A;
TOXIN;
ANTINEOPLASTIC ACTIVITY;
CANCER THERAPY;
CELL CYCLE S PHASE;
CELL PROLIFERATION;
CELL TRANSFORMATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG EFFECT;
DRUG TARGETING;
EUKARYOTIC CELL;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
PROTEIN PROCESSING;
PROTEIN SYNTHESIS INHIBITION;
ANTINEOPLASTIC AGENTS;
CELL CYCLE;
CELL DEATH;
CHELATING AGENTS;
CYTARABINE;
DEFEROXAMINE;
EPIDERMAL GROWTH FACTOR;
EXOTOXINS;
HUMANS;
INTERFERON TYPE II;
IRON;
KINETICS;
LEUKEMIA;
LYSINE;
OROPHARYNGEAL NEOPLASMS;
PEPTIDE INITIATION FACTORS;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RNA-BINDING PROTEINS;
TRANSFORMING GROWTH FACTOR ALPHA;
TUMOR CELLS, CULTURED;
ARA;
EUKARYOTA;
MAMMALIA;
|
EID: 0034467556
PISSN: 00652598
EISSN: None
Source Type: Book Series
DOI: None Document Type: Conference Paper |
Times cited : (33)
|
References (42)
|